首页|胃癌新辅助化疗疗效的影响因素分析

胃癌新辅助化疗疗效的影响因素分析

扫码查看
目的 探讨与分析胃癌新辅助化疗(neoadjuvant chemotherapy,NAC)疗效的影响因素.方法 回顾性选取2019年1月—2022年6月在苏州大学第三附属医院胃肠外科接受NAC治疗的60例胃癌(gastric cancer,GC)患者的临床资料.根据肿瘤消退分级(tumor regression grade,TRG)将其分为有效组(n=33)和无效组(n=27).比较两组患者的临床资料,采用多因素Logistic回归分析筛选可预测疗效的独立因素.结果 本研究中NAC有效率为55.00%(33/60).Logistic回归分析结果显示,胃癌患者NAC前较高的血小板分布宽度(OR=18.629,95%CI:3.448~180.463)、较高的腺苷脱氨酶(OR=12.798,95%CI:2.554~104.447)、较晚的临床T分期(OR=19.398,95%CI:2.386~372.960)是NAC治疗胃癌疗效的独立危险因素(P均<0.05);较高的尿素水平(OR=0.045,95%CI:0.005~0.094)是NAC治疗胃癌疗效的独立保护因素(P<0.05).结论 NAC前患者的肿瘤临床T分期、血小板分布宽度、腺苷脱氨酶、尿素是预测治疗疗效的独立影响因素.在筛查适合开展NAC的胃癌患者时,应重点关注上述指标.
Analysis of Factors Influencing the Efficacy of Neoadjuvant Chemotherapy in Gastric Cancer
Objective To explore and analyze the factors influencing the efficacy of neoadjuvant chemotherapy(NAC)for gastric cancer.Methods The clinical data of sixty patients with gastric cancer(GC)who received NAC treatment in the Department of Gastroenterology at the Third Affiliated Hospital of Soochow University from January 2019 to June 2022 were Retrospectively selected.According to the tumor regression grade(TRG),it was divided into an effective group(n=33)and an ineffective group(n=27).Compare the clinical data of two groups of patients and use multivariate logistic regression analysis to screen for independent factors that can predict therapeutic efficacy.Results The effec-tive rate of NAC in this study was 55.00% (33/60).Logistic regression analysis showed that patients with gastric can-cer had higher platelet distribution width before NAC(OR=18.629,95%CI:3.448-180.463)and higher adenosine de-aminase(OR=12.798,95%CI:2.554-104.447)and late clinical T stage(OR=19.398,95%CI:2.386-372.960)were in-dependent risk factors for the efficacy of NAC for gastric cancer(all P<0.05).Higher urea levels(OR=0.045,95%CI:0.005-0.094)were independent protective factors for the efficacy of NAC in gastric cancer(P<0.05).Conclusion The clinical T stage of tumors,platelet distribution width,adenosine deaminase,and urea in patients before NAC are inde-pendent influencing factors for predicting treatment efficacy.When screening gastric cancer patients suitable for NAC,special attention should be paid to the above indicators.

Gastric cancerNeoadjuvant chemotherapyCurative effect

周杰、王海涛

展开 >

苏州大学附属第三医院胃肠外科,江苏 常州 213002

胃癌 新辅助化疗 疗效

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(17)
  • 10